STUDY OF COMPARATIVE PHARMACOKINETICS AND BIOEQUIVALENCE OF DRUGS AMLODIPINE + VALSARTAN AND EXFORGE®
- Authors: Khokhlov A.L1,2, Miroshnikov A.E3, Khokhlov A.A3, Pozdnyakov N.O3, Voronina E.A1, Gerasimchuk S.A3, Rybachkova Y.V3, Manko K.S4, Dubovik E.G4
-
Affiliations:
- Road clinical hospital at Yaroslavl station JSC “Russian Railways”
- “Yaroslavl medical University”
- ClinPharmInvest
- AKRIKHIN
- Issue: Vol 24, No 6 (2018)
- Pages: 299-305
- Section: Articles
- URL: https://journals.rcsi.science/0869-2106/article/view/38476
- DOI: https://doi.org/10.18821/0869-2106-2018-24-6-299-305
- ID: 38476
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
A. L Khokhlov
Road clinical hospital at Yaroslavl station JSC “Russian Railways”; “Yaroslavl medical University”150047, Yaroslavl, Russian Federation; 150000, Yaroslavl, Russian Federation
A. E Miroshnikov
ClinPharmInvest150047, Yaroslavl, Russian Federation
A. A Khokhlov
ClinPharmInvest150047, Yaroslavl, Russian Federation
N. O Pozdnyakov
ClinPharmInvest150047, Yaroslavl, Russian Federation
E. A Voronina
Road clinical hospital at Yaroslavl station JSC “Russian Railways”150047, Yaroslavl, Russian Federation
S. A Gerasimchuk
ClinPharmInvest150047, Yaroslavl, Russian Federation
Yu. V Rybachkova
ClinPharmInvest150047, Yaroslavl, Russian Federation
K. S Manko
AKRIKHIN142450, Moscow region, Noginsk district, Staraya Kupavna, Russian Federation
E. G Dubovik
AKRIKHIN142450, Moscow region, Noginsk district, Staraya Kupavna, Russian Federation
References
- Шуникова М.И., Хохлов А.Л., Соснин А.Ю. Сравнительная оценка органопротективных свойств фозиноприла, амлодипина и метопролола у больных артериальной гипертонией. Consilium Medicum. 2008; 10(11): 30-5.
- Шальнова С.А., Кукушкин С., Маношкина Е., Тимофеева Т. Артериальная гипертензия и приверженность терапии. Врач. 2009: 12: 39-42.
- Конради А.О. Ключевые достижения в комбинированной антигипертензивной терапии последних лет. АГ. 2012; 6: 491-6.
- Хохлов А.Л., Рыска М., Кукес В.Г. Теоретические и практические основы проведения исследований воспроизведенных лекарственных препаратов: монография. ООО Фотолайф. 2017: 227.
- Poldermans D., Glazes R., Kargiannis S., Wernsing M., Kaczor J., Chiang Y.T., Yen J., Gamboa R., Fomina I. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Clin. Ther. 2007; 29(2): 279-89.
- Destro M., Luckow A., Samson M., Kandra A., Brunel P. Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS Study. J. Am. Soc. Hypertens. 2008; 2(4): 294-302.
- Khokhlov A.L., Ryska M., Kukes V.G. Theoretical and practical bases of research of reproduced medicinal products: monograph. LLC Fotolajf, 2017; 227. (in Russian)
- Smith T.R., Philipp T., Vaisse B., Bakris G.L., Wernsing M., Yen J., Glazer R. Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies. J. Clin. Hypertens. 2007; 9(5): 355-64.
- Public Assessment Report Decentralised Procedure, (Valsartan), Procedure No: UK/H/3444/001-4/DC, UK licenceNo:PL 34771/0019-22, MacleodsPharma UK Limited, Medicines and Healthcare products Regulatory Agency, 2012.
- Public Assessment Report Scientific discussion, Valsartan “Mylan”, 40 mg, 80 mg and 160 mg capsules, hard, Valsartan, Procedure No: DK/H/1613/001-003/DC, 2010.
- Public Assessment Report Scientific discussion, Valsartan Cristers, 40 mg, 80 mg and 160 mg film-coated tablets (Valsartan), FR/H/410/01-03/DC, Applicant: Substipharm, 2011.
- Spinola A.C. et al. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions. Clin Ther. 2009. 31(9): 1992-2001.
- UK Public Assessment Report, Valsartan 40 mg film-coated tablets, Valsartan 80 mg film-coated tablets, Valsartan 160 mg film-coated tablets (valsartan), PL 20092/0045-7, Safeguarding public health, Medicines and Healthcare products Regulatory Agency, 2010.
- Carvalho M. et al. Amlodipine bioequivalence study: quantification by liquid chromatography coupled to tandem mass spectrometry. Biopharm Drug Dispos. 2001. 22(9): 383-90.
- Liu Y. et al. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose,randomized, two-way crossover study in healthy Chinese male volunteers. Clin Ther. 2009; 31(4): 777-83.
- Setiawati E. et al. Bioequivalence Study of Two Amlodipine Tablet Formulations. Maj KedoktIndon. 2008; 58(2).
- Al-Tamimi J.J.I. Bioequivalence and Pharmacokinetics of Two Formulations of Amlodipine Tablets in Healthy Subjects. Iraqi J Pharm Sci. 2014; 23(1).